Development and Validation of a Risk Nomogram Model for Predicting Revascularization After Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome

References

• FengJ, WuX. [Research progress in fractional flow reserve]. Zhongguo Yi Liao Qi Xie Za Zhi. 2020;44(2):179–184. Chinese.32400995
   PubMedGoogle Scholar
• Sanchis-GomarF, Perez-QuilisC, LeischikR, LuciaA. Epidemiology of coronary heart disease and acute coronary syndrome. Ann Transl Med. 2016;4(13):256. doi:10.21037/atm.2016.06.3327500157
   PubMed Web of Science ®Google Scholar
• WangF, XuCQ, HeQ, et al. Genome-wide association identifies a susceptibility locus for coronary artery disease in the Chinese Han population. Nat Genet. 2011;43(4):345–349. doi:10.1038/ng.78321378986
   PubMed Web of Science ®Google Scholar
• LeschikJ, BauerT. [Acute coronary syndrome]. MMW Fortschr Med. 2018;160(14):52–61. German. doi:10.1007/s15006-018-0022-2
   Google Scholar
• WuJ, ZhaoL, LinK, LuL, LuoC. Chinese herbal medicines for restenosis after percutaneous coronary intervention: a meta-analysis of randomized controlled trials. J Altern Complement Med. 2019;25(10):983–992. doi:10.1089/acm.2018.051631464515
   PubMed Web of Science ®Google Scholar
• StolkerJM, CohenDJ, KennedyKF, et al. Repeat revascularization after contemporary percutaneous coronary intervention: an evaluation of staged, target lesion, and other unplanned revascularization procedures during the first year. Circ Cardiovasc Interv. 2012;5(6):772–782. doi:10.1161/CIRCINTERVENTIONS.111.96780223093553
   PubMed Web of Science ®Google Scholar
• FerencM, BuettnerHJ, GickM, et al. Clinical outcome after percutaneous treatment of de novo coronary bifurcation lesions using first or second generation of drug-eluting stents. Clin Res Cardiol. 2016;105(3):230–238. doi:10.1007/s00392-015-0911-726329585
   PubMed Web of Science ®Google Scholar
• GiglioliC, CecchiE, VladiL, et al. Comparison between drug-eluting and bare metal stent on ST-elevation myocardial infarction outcome: should second-generation drug-eluting stent be preferred?J Cardiol. 2014;63(4):296–301. doi:10.1016/j.jjcc.2013.09.00724365386
   PubMed Web of Science ®Google Scholar
• TaniwakiM, StefaniniGG, SilberS, et al. 4-year clinical outcomes and predictors of repeat revascularization in patients treated with new-generation drug-eluting stents: a report from the RESOLUTE all-comers trial (A randomized comparison of a zotarolimus-eluting stent with an everolimus-eluting stent for percutaneous coronary intervention). J Am Coll Cardiol. 2014;63(16):1617–1625.24530680
   PubMed Web of Science ®Google Scholar
• ParkSY. Nomogram: an analogue tool to deliver digital knowledge. J Thorac Cardiovasc Surg. 2018;155(4):1793. doi:10.1016/j.jtcvs.2017.12.10729370910
   PubMed Web of Science ®Google Scholar
• AndersonJL, AdamsCD, AntmanEM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing committee to revise the 2002 guidelines for the management of patients with unstable angina/Non-ST-elevation myocardial infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol. 2007;50(7):e1–e157.17692738
   PubMed Web of Science ®Google Scholar
• KushnerFG, HandM, SmithSCJr, et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2009;54(23):2205–2241.19942100
   PubMed Web of Science ®Google Scholar
• LevineGN, BatesER, BlankenshipJC, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv. 2012;79(3):453–495.22328235
   PubMed Web of Science ®Google Scholar
• IftikharSF, HuP. Complex Coronary Artery Lesions. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2021, StatPearls Publishing LLC; 2021.
   Google Scholar
• MedinaA, Suárez de LezoJ, PanM. [A new classification of coronary bifurcation lesions]. Rev Esp Cardiol. 2006;59(2):183. Portuguese.16540043
   PubMed Web of Science ®Google Scholar
• TurgutO, YilmazA, YaltaK, et al. Tortuosity of coronary arteries: an indicator for impaired left ventricular relaxation?Int J Cardiovasc Imaging. 2007;23(6):671–677. doi:10.1007/s10554-006-9186-417216126
   PubMed Web of Science ®Google Scholar
• HafeezY, VargheseV. Chronic Total Occlusion of the Coronary Artery. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2021, StatPearls Publishing LLC; 2021.
   Google Scholar
• CosgraveJ, MelziG, Biondi-ZoccaiGG, et al. Drug-eluting stent restenosis the pattern predicts the outcome. J Am Coll Cardiol. 2006;47(12):2399–2404. doi:10.1016/j.jacc.2006.02.04616781366
   PubMed Web of Science ®Google Scholar
• ShahP, BajajS, VirkH, BikkinaM, ShamoonF. Rapid progression of coronary atherosclerosis: a review. Thrombosis. 2015;2015:634983. doi:10.1155/2015/63498326823982
   PubMedGoogle Scholar
• HwangD, LeeJM, LeeHJ, et al. Influence of target vessel on prognostic relevance of fractional flow reserve after coronary stenting. EuroIntervention. 2019;15(5):457–464. doi:10.4244/EIJ-D-18-0091330561367
   PubMed Web of Science ®Google Scholar
• IglesiasJF, MullerO, LosdatS, et al. Multivessel percutaneous coronary intervention with thin-strut biodegradable versus durable polymer drug-eluting stents in ST-segment elevation myocardial infarction: a subgroup analysis of the BIOSTEMI randomized trial. Int J Cardiol. 2021;334:37–41. doi:10.1016/j.ijcard.2021.04.03433887341
   PubMed Web of Science ®Google Scholar
• KramerJR, MatsudaY, MulliganJC, AronowM, ProudfitWL. Progression of coronary atherosclerosis. Circulation. 1981;63(3):519–526. doi:10.1161/01.CIR.63.3.5197460236
   PubMed Web of Science ®Google Scholar
• GlaserR, SelzerF, FaxonDP, et al. Clinical progression of incidental, asymptomatic lesions discovered during culprit vessel coronary intervention. Circulation. 2005;111(2):143–149. doi:10.1161/01.CIR.0000150335.01285.1215623544
   PubMed Web of Science ®Google Scholar
• LoopFD. Progression of coronary atherosclerosis. N Engl J Med. 1984;311(13):851–853. doi:10.1056/NEJM1984092731113116332275
   PubMed Web of Science ®Google Scholar
• SchoenenbergerAW, JamshidiP, KobzaR, et al. Progression of coronary artery disease during long-term follow-up of the Swiss Interventional Study on Silent Ischemia Type II (SWISSI II). Clin Cardiol. 2010;33(5):289–295. doi:10.1002/clc.2077520513067
   PubMed Web of Science ®Google Scholar
• SchmittVH, HobohmL, MünzelT, WenzelP, GoriT, KellerK. Impact of diabetes mellitus on mortality rates and outcomes in myocardial infarction. Diabetes Metab. 2020;47(4):101211. doi:10.1016/j.diabet.2020.11.00333259948
   PubMed Web of Science ®Google Scholar
• LimSS, YangYL, ChenSC, et al. Association of variability in uric acid and future clinical outcomes of patient with coronary artery disease undergoing percutaneous coronary intervention. Atherosclerosis. 2020;297:40–46. doi:10.1016/j.atherosclerosis.2020.01.02532062138
   PubMed Web of Science ®Google Scholar
• VisternichanO, JalaliSF, TaizhanovaD, MuravlyovaL, IgimbayevaG. Dynamic changes in purine catabolism in patients with acute coronary syndrome that underwent percutaneous coronary intervention. Caspian J Intern Med. 2019;10(1):86–91.30858946
   PubMed Web of Science ®Google Scholar
• BigazziF, MinichilliF, SbranaF, et al. Gender difference in lipoprotein(a) concentration as a predictor of coronary revascularization in patients with known coronary artery disease. Biochim Biophys Acta Mol Cell Biol Lipids. 2021;1866(3):158869. doi:10.1016/j.bbalip.2020.15886933333178
   PubMed Web of Science ®Google Scholar
• FarkouhME, GodoyLC, BrooksMM, et al. Influence of LDL-cholesterol lowering on cardiovascular outcomes in patients with diabetes mellitus undergoing coronary revascularization. J Am Coll Cardiol. 2020;76(19):2197–2207. doi:10.1016/j.jacc.2020.09.53633153578
   PubMed Web of Science ®Google Scholar
• ArnoldSV, SmolderenKG, KennedyKF, et al. Risk factors for rehospitalization for acute coronary syndromes and unplanned revascularization following acute myocardial infarction. J Am Heart Assoc. 2015;4(2). doi:10.1161/JAHA.114.001352
   Web of Science ®Google Scholar
• YinZX, ZhouYJ, LiuXL, HanHY, YangSW. Clinical predictors for progression of nonintervened nonculprit coronary lesions despite low-density lipoprotein cholesterol less than 1.8 mmol/L after successful stent implantation. Coron Artery Dis. 2011;22(1):49–54. doi:10.1097/MCA.0b013e328342360721150778
   PubMed Web of Science ®Google Scholar
• TriantafyllisAS, BennettJ, PagoureliasE, et al. Long-term outcomes after percutaneous revascularization of complex coronary bifurcation lesions using a dedicated self-expanding biolimus-eluting stent system. Cardiol J. 2018;25(4):470–478. doi:10.5603/CJ.a2017.014129240962
   PubMed Web of Science ®Google Scholar
• OhyaM, MorimotoT, KuboS, et al. Two-year outcomes and predictors of target lesion revascularization for non-left main coronary bifurcation lesions following two-stent strategy with 2nd-generation drug-eluting stents. Circ J. 2018;82(3):798–806. doi:10.1253/circj.CJ-17-109229269613
   PubMed Web of Science ®Google Scholar
• BernhardH, WipflerP, LeschnikB, et al. Relationship between thrombin generation and carotid intima-media thickness. Hamostaseologie. 2010;30(Suppl 1):S168–71.21042684
   PubMed Web of Science ®Google Scholar
• GénéreuxP, MadhavanMV, MintzGS, et al. Ischemic outcomes after coronary intervention of calcified vessels in acute coronary syndromes. Pooled analysis from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) and ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) TRIALS. J Am Coll Cardiol. 2014;63(18):1845–1854.24561145
   PubMed Web of Science ®Google Scholar
• EscárcegaRO, BakerNC, LipinskiMJ, et al. Current application and bioavailability of drug-eluting stents. Expert Opin Drug Deliv. 2014;11(5):689–709. doi:10.1517/17425247.2014.88805424533457
   PubMed Web of Science ®Google Scholar
• EllisSG, ShawRE, GershonyG, et al. Risk factors, time course and treatment effect for restenosis after successful percutaneous transluminal coronary angioplasty of chronic total occlusion. Am J Cardiol. 1989;63(13):897–901. doi:10.1016/0002-9149(89)90135-52522727
   PubMed Web of Science ®Google Scholar
• AmbroseJA, BaruaRS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol. 2004;43(10):1731–1737. doi:10.1016/j.jacc.2003.12.04715145091
   PubMed Web of Science ®Google Scholar